JOSÉ LUIS
REVUELTA DOVAL
Investigador en el periodo 1986-2023
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (6)
2019
-
A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity
Journal of Molecular Biology, Vol. 431, Núm. 5, pp. 956-969
2018
-
Ferredoxin-linked flavoenzyme defines a family of pyridine nucleotide-independent thioredoxin reductases
Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Núm. 51, pp. 12967-12972
2017
-
A New Member of the Thioredoxin Reductase Family from Early Oxygenic Photosynthetic Organisms
Molecular Plant
-
Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine
PLoS Neglected Tropical Diseases, Vol. 11, Núm. 8
2015
-
Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases
Nature Communications, Vol. 6
2013
-
Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast
Journal of Biological Chemistry, Vol. 288, Núm. 12, pp. 8405-8418